Please assess the completion status of the following clinical trial:

Trial Title: Pilot Study of Pentoxifylline for Hepatopulmonary Syndrome

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patient undergoing liver transplantation evaluation for cirrhosis~* HPS (positive contrast echocardiography, hypoxemia, no other cause)~* PaO2 \< 65mmHg~* ability and willingness to give informed consent~Exclusion Criteria:~* Patients under the age of 19~* active bacterial infections~* known malignancy~* intrinsic cardiopulmonary disease~* known intolerance to pentoxifylline

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- single (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).